Evidence map›Paper›PMID 31941527›Full record

Trial reportTrials2020

Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial.

Elizabeth A O'Connor, William M Vollmer, Amanda F Petrik, Beverly B Green, Gloria D Coronado

Registry-linked trialOpen access · goldAbstract readRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in Trials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01742065 (Strategies and Opportunities to Stop Colon Cancer in Priority Populations), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01742065 nacompletednot on this map

Strategies and Opportunities to Stop Colon Cancer in Priority Populations

TypeinterventionalSponsorKaiser PermanenteRan2013 to 2018Enrolled62,155ConditionsColorectal CancerArmsAuto Plus
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Geographical Disparities in Faecal Immunochemical Test-Based Colorectal Cancer Screening Participation and Positivity Rates: A Systematic Review and Meta-Analysis.Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals · 2026
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Black and White Differences in Colorectal Cancer Screening and Screening Outcomes: A Narrative Review.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Elizabeth A O'ConnorKaiser Permanente Center for Health Research, 3800 N. Interstate Avenue, Portland, OR, 97227, USA. Elizabeth.OConnor@kpchr.org.ORCID http://orcid.org/0000-0003-0571-0768
William M VollmerKaiser Permanente Center for Health Research, 3800 N. Interstate Avenue, Portland, OR, 97227, USA.
Amanda F PetrikKaiser Permanente Center for Health Research, 3800 N. Interstate Avenue, Portland, OR, 97227, USA.
Beverly B GreenKaiser Permanente Washington Health Research Institute, 1730 Minor Avenue, Suite, Seattle, WA, 1600, USA.
Gloria D CoronadoKaiser Permanente Center for Health Research, 3800 N. Interstate Avenue, Portland, OR, 97227, USA.
Kaiser Permanente Center for Health Research · USKaiser Permanente Washington Health Research Institute · US

Funding

Strategies and Opportunities to Stop Colon Cancer in Priority PopulationsUH3CA188640 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CORONADO, GLORIA D · 2014 to 2017
$6.1M
Strategies and Opportunities to Stop Colon Cancer in Priority PopulationsUH2AT007782 · NCCIH · KAISER FOUNDATION RESEARCH INSTITUTE · PI CORONADO, GLORIA D, DEVOE, JENNIFER E · 2012 to 2013
$859k
NCCIH NIH HHS UH2 AT007782NCI NIH HHS UH3 CA188640NCI NIH HHS UH3CA188640NIH HHS UH2AT007782
6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) screening rates remain suboptimal, particularly in low-income and underserved populations. Mailed fecal immunochemical testing (FIT) may overcome common barriers to screening; however, the effect of mailed FIT kits may differ across important subpopulations. The goal of the current study was to examine sociodemographic and health-related factors that moderate the effect of an intervention of automated direct mail of FIT kits at health clinics serving low-income populations.

methodsThis study is a secondary analysis of the Strategies and Opportunities to Stop Colon Cancer in Priority Populations (STOP CRC) study, a cluster-randomized pragmatic trial to increase uptake of CRC screening in patients seen at federally qualified health centers. The intervention involved tools embedded in the electronic medical records to enable participating clinics to mail FIT kits and related materials to eligible participants. We examined the rate of FIT completion by potential moderating characteristics using electronic health record data supplemented by the American Community Survey and the Centers for Medicare & Medicaid Services Geographic Variation datasets, linked via geocoding to patients' addresses. All patients aged 50-75 seen in participating health clinics who were eligible for CRC screening were included.

resultsAlthough not always statistically significant, we saw a consistent pattern of increased FIT return rates among intervention participants compared to control participants across all subgroups studied, with incidence rate ratios (IRRs) generally ranging from 1.25 to 1.50. FIT completion in the intervention group ranged from 15 and 20% across subpopulations, typically three to six percentage points higher than the control group participants. The only moderator with a statistically significant interaction was race: persons of Asian descent showed a twofold response to the intervention (adjusted incidence rate ratio [aIRR] = 2.06, 95% confidence interval 1.41 to 3.00).

conclusionsResponse to a mailed FIT intervention was generally consistent across a wide range of individual and neighborhood-level patient characteristics, including typically underserved patients and those in low-resource communities.

trial registrationClinicalTrials.gov, NCT01742065. Registered on 5 December 2012.

Indexed as

AgedCase-Control StudiesColonic NeoplasmsColorectal NeoplasmsElectronic Health RecordsFecesFemaleHumansIncidenceMaleMass ScreeningMedicaidMedicareMiddle AgedPostal ServiceUnited StatesColorectal cancerDisparitiesFecal immunochemical testPreventionScreening

Identifiers

PMID31941527
PMCPMC6964086
OpenAlexW3000390916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.